Every drug program faces three critical questions: Did we pick the right target? Is our candidate safe and effective? Are we treating the right patients? While genomics and transcriptomics reveal what could happen, proteins show what is happening—where mechanism, efficacy, and toxicity are actually revealed. Yet proteomics remains underutilized due to cost and scalability barriers, forcing teams to infer biology rather than measure it directly. Discover how Nomic's scalable, quantitative proteomics platform transforms this missing layer into the discovery engine that drives confident decisions from hit to clinic.